Lori-AnnFisher University of the West Indies, MonaJamaica

Day 1 - Sunday April 14, 2024

Time	Session

09:00 am 10:30 am	APOL1 Targeted Therapies: Who to Test and Which Disease to Treat? FernandaSales Luiz Vianna Chairperson fslvianna@gmail.comUniversidade Federal do Rio Grande do SulBrazil OpeyemiOlabisi Chairperson opeyemi.olabisi@duke.eduDuke University School of MedicineUnited States Fatiu AbiolaArogundade Chairperson fatiu3@yahoo.comObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria Nigeria Ethical Aspects of Race-based Genetic Testing AnaIltis Speaker iltisas@wfu.eduWake Forest UniversityUnited States Contribution of ApoL1 Risk Genotype to HIVAN SaraladeviNaicker Speaker Saraladevi.Naicker@wits.ac.zaUniversity of the Witwatersrand South Africa Contribution of APOL1 Risk Alleles to Kidney Disease in West Africa DwomoaAdu Speaker dwoms@blueyonder.co.ukUniversity of Ghana Medical SchoolGhana Targeting ApoL1: A 12-Year Journey from Genetic Discovery to Phase 2 Trials OgoEgbuna Speaker ogo_egbuna@vrtx.comVertex Pharmaceuticals IncUnited States Q and A Hall C2
11:00 am 12:00 pm	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) AgnesFogo Chairperson agnes.fogo@vanderbilt.eduUnited States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria Hall A
04:30 pm 05:30 pm	Policy and Advocacy Approaches Lori-AnnFisher Chairperson lori2k15@gmail.comUniversity of the West Indies, MonaJamaica MarcelloTonelli Chairperson cello@ucalgary.caSenior Associate Dean (Clinical Research), CummingCanada Universal Health Coverage for Kidney Diseases: Feasibility, Barriers, and Opportunities for Improving Global Kidney Health VivekanandJha Speaker vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia The Role of Kidney Health Advocacy Organizations in Reducing the Global Burden of Kidney Diseases ValerieLuyckx Speaker valerie.luyckx@uzh.chUniversity of ZurichSwitzerland A Case for National Prevention Programs to Manage CKD IkechiOkpechi Speaker iokpechi@ualberta.caUniversity of AlbertaCanada Q and A Hall A